Image

Young Adult EC Use and Respiratory Outcomes

Young Adult EC Use and Respiratory Outcomes

Non Recruiting
18-25 years
All
Phase N/A

Powered by AI

Overview

E-cigarette (EC) use continues to increase among youth, and EC may be detrimental to youth respiratory health. Public health officials and the Food and Drug Administration (FDA) can now regulate ECs. The proposed study uses naturalistic assessments called ecological momentary assessment (EMA) to understand how ECs use may impact the respiratory health of youth and young adult users compared to never-using peers.

Description

Using a prospective longitudinal design, 150 youth and young adults aged 18-25 years (100 exclusive-EC users; 50 never-users) will complete 5 sessions (baseline, 3-,6-, 9-, and 12-months). Sessions will include naturalistic measures such as measures of respiratory health, questionnaires, and nasal epithelial lining fluid (NELF) nasal samples. To assess acute changes in pulmonary functioning related to tobacco product use, participants will complete twice daily EMA and home-based spirometry for the 2 weeks following the Day 1 session and the 2 weeks prior to each follow-up zoom session. Never-users will participate in a brief 15-30-minute individual interview consisting of questions related to reasons for never-EC use and other protective factors that will be used to build future prevention messaging.

Eligibility

Inclusion Criteria:

  1. own a smartphone and willing to add study EMA and spirometry application to it.
  2. a current exclusive-EC user (endorse ≥weekly use over the past 3 months) and report never trying OTPs
  3. between the ages of 18-25 years old at the time of enrollment
  4. read and speak English
  5. willing to complete five, 2-week periods of daily EMA and home-based spirometry
  6. never-users must indicate never trying any tobacco product to be eligible for enrollment

Exclusion Criteria:

  1. self-reported diagnosis of lung disease including cystic fibrosis or chronic obstructive pulmonary disease; we will not exclude youth who have asthma, but will incorporate this as a covariate during analyses
  2. unstable or significant psychiatric conditions (past and stable conditions will be allowed)
  3. history of cardiac event or distress within the past 3 months
  4. are currently pregnant, planning to become pregnant, or breastfeeding

Study details
    E Cig Use

NCT04395274

Ohio State University Comprehensive Cancer Center

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.